Clinical Trial

Testing Experimental Parkinson's Disease Medication

Study Description

Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

The purpose of this study is to investigate the safety of a single dose of Lu AF82422, how well it is tolerated, how the drug effects the body and what the body does to the drug in healthy non-Japanese and Japanese subjects and in patients with Parkinson's disease

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Lu AF82422

Lu AF82422 - concentrate for solution for infusion; vials containing 50mg/ml, single dose

Drug - Placebo

placebo - concentrate for solution for infusion, single dose

Additional Information

Official Study Title

Interventional, Randomized, Double-blind, Sequential-group, Placebo-controlled, Single-ascending-dose Study Investigating the Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Properties of Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

Clinical Trial ID

NCT03611569

ParticipAid ID

b4x8Vb